Epithalon
Epithalon (Epitalon)
The telomerase-activating longevity peptide with the most extensive anti-aging research.
Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptides discussed may be research compounds not approved for human use. Always consult a qualified healthcare provider before starting any peptide protocol. Read our full disclaimer →
Quick Reference
| Peptide Class | Tetrapeptide (Ala-Glu-Asp-Gly) |
| Half-Life | ~1–2 hours |
| Administration | Subcutaneous injection, Intravenous (clinical settings) |
| Typical Dosage | 5–10 mg/day for 10–20 days (cycled) |
| Cycle Length | 10–20 day cycles, 1–2x per year |
| Evidence Level | Moderate Preclinical / Emerging Human |
| Legal Status | Research compound — not FDA-approved for human use |
| Approximate Cost | $40–$100 per cycle |
How Epithalon Works
Activates telomerase enzyme to maintain telomere length; regulates pineal gland function and melatonin production.
Epithalon is a synthetic tetrapeptide derived from the pineal gland peptide Epithalamin. Its primary mechanism involves the activation of telomerase — the enzyme responsible for maintaining and extending telomere length. Telomere shortening is a fundamental mechanism of cellular aging; by activating telomerase, Epithalon theoretically slows this process. It also regulates pineal gland function, normalizing melatonin production and circadian rhythm, which explains its sleep-improving effects. Additionally, it modulates the hypothalamic-pituitary axis and exhibits antioxidant properties.
Evidence Base
Preclinical Evidence
Russian research spanning 30+ years demonstrates lifespan extension in animal models, telomere maintenance, and improvements in immune function. Studies show 24–40% increases in mean lifespan in some rodent models.
Human Evidence
Limited but intriguing human data from Russian clinical research. Studies in elderly patients show improvements in sleep quality, immune markers, and quality-of-life measures. No large-scale Western RCTs have been completed.
Anecdotal Evidence
Epithalon has a dedicated following in the longevity community. Users report improved sleep quality, increased energy, and a general sense of vitality. The cyclic dosing protocol (10–20 days, 1–2x/year) is widely followed based on the original Russian research protocols.
Key PubMed References:
Safety Profile
Side Effects
Generally well-tolerated. Mild injection-site reactions. No serious adverse events documented in the literature.
Contraindications
No established contraindications. Theoretical caution in individuals with cancer due to telomerase activation (though evidence for risk is lacking).
PeptidePilot Assessment
Epithalon is PeptidePilot's top recommendation for users in the Longevity domain who prioritize cellular anti-aging and sleep quality. In our algorithm, it scores highest for users aged 40+ who report sleep issues, energy decline, and a strong interest in longevity optimization. The cyclic dosing protocol makes it practical for users who prefer infrequent intervention.
📊 12% of PeptidePilot users with longevity and anti-aging as primary goals receive Epithalon as their top match
Frequently Asked Questions
Explore More Peptides
The most researched healing peptide for joints, tendons, and gut tissue.
Systemic tissue repair and anti-inflammatory recovery for athletes and injury rehabilitation.
The cleanest growth hormone secretagogue for muscle growth, fat loss, and sleep quality.
Extended-release GHRH analogue that amplifies and sustains growth hormone pulses.
The clinically established GHRH analogue with the longest safety record in anti-aging medicine.
The most clinically validated peptide for weight loss and metabolic health.